X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation
Image: Xiaoxi Wei, Ph.D., Co-founder and CEO of X-Therma, with the TimeSeal® Oversubscribed round propels company towards clinical trials and global market expansion, promising